Context Cancer pain can appear with spikes of higher intensity. Breakthrough cancer pain
(BTCP) is the most common term for the transient exacerbations of pain, but the ability of the …

Abstract Background and Objectives Proper breakthrough cancer pain (BTcP) management
is of pivotal importance. Although rapid-acting, oral and nasal transmucosal, fentanyl …

Breakthrough cancer pain (BTcP) is an episode of severe pain that “breaks through” a
period of persistent pain at least partly controlled by a stable opioid regimen. Although …

Objectives: To explore the effect of breakthrough cancer pain (BTcP) treatment on quality of
sleep and other aspects of the health-related quality of life (HRQoL) in patients with cancer …

Background: The aim of this study was to identify potential variables influencing the clinical
presentation of breakthrough cancer pain (BTP). Methods: Cancer patients with a diagnosis …

Objectives Breakthrough cancer pain (BTP) represents a treatment challenge. Objectives
were to examine the prevalence and characteristics of BTP in an international sample of …

Controversies exist about the definition and epidemiology of breakthrough cancer pain
(BTcP), the pharmacological treatment options, drug dosing, and how to select the …

Objectives: Despite guidelines, a large percentage of cancer patients continue to suffer from
ineffectively treated pain. The authors undertook this survey to assess the strengths and …

Simple Summary Pain is one of the most common and debilitating symptoms in cancer
patients. A clinical peculiarity of cancer pain is the breakthrough cancer pain (BTcP), which …

Breakthrough cancer pain (BTcP) is a complex and variegate phenomenon that may change
its presentation during the course of patients' disease in the same individual. An appropriate …